PUBLISHER: The Business Research Company | PRODUCT CODE: 1513245
PUBLISHER: The Business Research Company | PRODUCT CODE: 1513245
Sedative-Hypnotic Drugs Global Market Report 2024
A sedative-hypnotic drug is a chemical substance employed to alleviate tension, anxiety, and induce a sense of calm (sedative effect), or to facilitate sleep (hypnotic effect). These drugs act by suppressing the limbic system, responsible for emotional and behavioral responses, as well as the reticular formation, which regulates sleep patterns and consciousness.
Key types of sedative-hypnotic drugs include benzodiazepines, barbiturates, antihistamines, nonbenzodiazepines, and others. Benzodiazepines, for instance, decrease activity in the brain and nervous system, offering tranquilizing effects used to alleviate symptoms of anxiety and insomnia. These medications can be administered through various routes, such as oral and parenteral, to treat various conditions including sleep disorders, anesthesia, and pain management. They are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies, serving diverse end-users including hospitals, specialty clinics, and home care settings.
The sedative-hypnotic drugs market research report is one of a series of new reports from The Business Research Company that provides sedative-hypnotic drugs market statistics, including sedative-hypnotic drugs industry global market size, regional shares, competitors with a sedative-hypnotic drugs market share, detailed sedative-hypnotic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the sedative-hypnotic drugs industry. This sedative-hypnotic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historical period can be attributed to several factors, including the expansion of direct-to-consumer advertising, heightened stress levels, increased prevalence of sleep disorders, and aging populations.
The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.00 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. Looking ahead to the forecast period, growth is anticipated due to the expansion of healthcare infrastructure, rising disposable incomes, a surge in lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and the expansion of telemedicine services. Key trends expected in the forecast period include a preference for non-benzodiazepine sedative-hypnotic drugs, advancements in drug delivery technologies, a heightened focus on personalized medicine, integration of digital health tools, and the emergence of new benzodiazepines.
The surge in stress levels is expected to drive the expansion of the sedative-hypnotic drugs market in the foreseeable future. Stress levels denote the mental or emotional exhaustion experienced by individuals due to challenging or unavoidable circumstances. Factors contributing to heightened stress levels include the struggle to balance work and personal life, inadequate coping mechanisms, and escalating work pressure among employees. Sedative-hypnotic drugs act as pharmacological agents primarily aimed at inducing a state of calmness, reducing anxiety levels, and relieving tension within individuals, often through their tranquilizing effects on the central nervous system. For example, as per a survey conducted by the American Psychiatric Association in December 2022, over 26% of American adults anticipated increased stress levels at the beginning of 2023, marking a rise from the 20% reported in the preceding year. Hence, the escalating stress levels are propelling the growth of the sedative-hypnotic drugs market.
Key players in the sedative-hypnotic drugs market are concentrating on broadening their product portfolio by introducing innovative products such as sublingual films for acute treatment of agitation, aiming to gain a competitive advantage. Sublingual films for acute agitation treatment are thin, dissolvable films containing medication placed under the tongue for rapid absorption into the bloodstream. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, unveiled IGALMI, a sublingual film designed for the acute management of agitation associated with schizophrenia or bipolar I or II disorder in adults. IGALMI represents the first new acute treatment for agitation linked to these disorders in nearly a decade, offering healthcare teams an innovative tool with its rapid onset of action and self-administered film format.
In June 2022, Eagle Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Acacia Pharma Group plc for an undisclosed sum. This strategic acquisition enabled Eagle Pharmaceuticals to expand its product portfolio by incorporating two drugs, 'BARHEMSYS' and 'BYFAVO', enhancing its presence in the acute care domain. Both companies aimed to bolster their position in the oncology and hospital sectors by addressing significant unmet clinical needs. Acacia Pharma Group plc, headquartered in the UK, specializes in the manufacturing of sedative-hypnotic drugs.
Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.
North America was the largest region in the sedative-hypnotic drugs market in 2023. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sedative-hypnotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sedative-hypnotic drugs market consists of sales of tablets, capsules, injectables, and liquid formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sedative-Hypnotic Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sedative-hypnotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sedative-hypnotic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sedative-hypnotic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Benzodiazepines; Barbiturates; Antihistamines; Nonbenzodiazepine; Other Drug Classes
- 2) By Route of Administration: Oral; Parenteral; Other Routes of Administration
- 3) By Disease Type: Sleep Disorders; Anesthesia; Pain; Other Disease Types
- 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
- 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
- Companies Mentioned: Sun Pharmaceutical Industries Inc.; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck And Co. Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sedative-Hypnotic Drugs Market Characteristics
3. Sedative-Hypnotic Drugs Market Trends And Strategies
4. Sedative-Hypnotic Drugs Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Sedative-Hypnotic Drugs Market Size and Growth
- 5.1. Global Sedative-Hypnotic Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Sedative-Hypnotic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Sedative-Hypnotic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Sedative-Hypnotic Drugs Market Segmentation
- 6.1. Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Benzodiazepines
- Barbiturates
- Antihistamines
- Nonbenzodiazepine
- Other Drug Class
- 6.2. Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Oral
- Parenteral
- Other Route of Administrations
- 6.3. Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Sleep Disorders
- Anesthesia
- Pain
- Other Disease Types
- 6.4. Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
- 6.5. Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals
- Specialty Clinics
- Homecare
- Other End-Users
7. Sedative-Hypnotic Drugs Market Regional And Country Analysis
- 7.1. Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Sedative-Hypnotic Drugs Market
- 8.1. Asia-Pacific Sedative-Hypnotic Drugs Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Sedative-Hypnotic Drugs Market
- 9.1. China Sedative-Hypnotic Drugs Market Overview
- 9.2. China Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Sedative-Hypnotic Drugs Market
- 10.1. India Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Sedative-Hypnotic Drugs Market
- 11.1. Japan Sedative-Hypnotic Drugs Market Overview
- 11.2. Japan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Sedative-Hypnotic Drugs Market
- 12.1. Australia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Sedative-Hypnotic Drugs Market
- 13.1. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Sedative-Hypnotic Drugs Market
- 14.1. South Korea Sedative-Hypnotic Drugs Market Overview
- 14.2. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Sedative-Hypnotic Drugs Market
- 15.1. Western Europe Sedative-Hypnotic Drugs Market Overview
- 15.2. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Sedative-Hypnotic Drugs Market
- 16.1. UK Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Sedative-Hypnotic Drugs Market
- 17.1. Germany Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Sedative-Hypnotic Drugs Market
- 18.1. France Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Sedative-Hypnotic Drugs Market
- 19.1. Italy Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Sedative-Hypnotic Drugs Market
- 20.1. Spain Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Sedative-Hypnotic Drugs Market
- 21.1. Eastern Europe Sedative-Hypnotic Drugs Market Overview
- 21.2. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Sedative-Hypnotic Drugs Market
- 22.1. Russia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Sedative-Hypnotic Drugs Market
- 23.1. North America Sedative-Hypnotic Drugs Market Overview
- 23.2. North America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Sedative-Hypnotic Drugs Market
- 24.1. USA Sedative-Hypnotic Drugs Market Overview
- 24.2. USA Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Sedative-Hypnotic Drugs Market
- 25.1. Canada Sedative-Hypnotic Drugs Market Overview
- 25.2. Canada Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Sedative-Hypnotic Drugs Market
- 26.1. South America Sedative-Hypnotic Drugs Market Overview
- 26.2. South America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Sedative-Hypnotic Drugs Market
- 27.1. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Sedative-Hypnotic Drugs Market
- 28.1. Middle East Sedative-Hypnotic Drugs Market Overview
- 28.2. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Sedative-Hypnotic Drugs Market
- 29.1. Africa Sedative-Hypnotic Drugs Market Overview
- 29.2. Africa Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Sedative-Hypnotic Drugs Market Competitive Landscape And Company Profiles
- 30.1. Sedative-Hypnotic Drugs Market Competitive Landscape
- 30.2. Sedative-Hypnotic Drugs Market Company Profiles
- 30.2.1. Sun Pharmaceutical Industries Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Merck And Co. Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Sun Pharmaceutical Industries Inc.
31. Sedative-Hypnotic Drugs Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi-Aventis AG
- 31.3. AstraZeneca Plc
- 31.4. Abbott Laboratories
- 31.5. GlaxoSmithKline plc
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Boehringer Ingelheim International GmbH
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Mylan N.V.
- 31.10. Fresenius Kabi AG
- 31.11. Eli Lilly and Co.
- 31.12. Aurobindo Pharma Limited
- 31.13. Cipla Inc.
- 31.14. Dr. Reddy's Laboratories Ltd.
- 31.15. Hikma Pharmaceuticals plc
32. Global Sedative-Hypnotic Drugs Market Competitive Benchmarking
33. Global Sedative-Hypnotic Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market
35. Sedative-Hypnotic Drugs Market Future Outlook and Potential Analysis
- 35.1 Sedative-Hypnotic Drugs Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Sedative-Hypnotic Drugs Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Sedative-Hypnotic Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
